Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
124.38
-0.06 (-0.05%)
Nov 20, 2024, 4:00 PM EST - Market closed

Ascendis Pharma Revenue

Ascendis Pharma had revenue of 57.83M EUR in the quarter ending September 30, 2024, with 20.40% growth. This brings the company's revenue in the last twelve months to 327.43M, up 115.54% year-over-year. In the year 2023, Ascendis Pharma had annual revenue of 266.72M with 421.20% growth.

Revenue (ttm)
327.43M EUR
Revenue Growth
+115.54%
P/S Ratio
19.44
Revenue / Employee
372,499 EUR
Employees
879
Market Cap
7.43B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023266.72M215.54M421.20%
Dec 31, 202251.17M43.40M557.93%
Dec 31, 20217.78M825.00K11.87%
Dec 31, 20206.95M-6.42M-48.01%
Dec 31, 201913.38M2.79M26.41%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Walgreens Boots Alliance 147.66B
Bausch + Lomb 4.68B
The Ensign Group 4.11B
Jazz Pharmaceuticals 3.99B
Bruker 3.24B
Chemed 2.38B
Repligen 633.51M
Legend Biotech 520.18M
Revenue Rankings